The dermatological state characterized by structural and functional decline resulting from the chronic reduction of circulating estrogen levels, most commonly observed in postmenopausal women. Clinically, this condition presents with accelerated skin aging, marked by reduced dermal collagen content, decreased skin thickness, diminished hydration, and impaired wound healing capacity. It reflects the profound trophic role of estrogen on cutaneous tissue homeostasis.
Origin
The term combines “estrogen deficient,” referring to the physiological state of hypoestrogenism, and “skin,” the affected organ. This clinical descriptor is fundamentally rooted in reproductive endocrinology and geriatric dermatology, particularly since the elucidation of menopause-related skin changes. It highlights the direct consequence of sex hormone withdrawal on the integumentary system.
Mechanism
Estrogen deficiency leads to a significant reduction in the activity of dermal fibroblasts, the primary cells responsible for synthesizing collagen, elastin, and hyaluronic acid. The absence of estrogenic signaling results in a net catabolic shift, accelerating the degradation of the extracellular matrix and reducing the skin’s water-binding capacity. Furthermore, the skin barrier function may be compromised due to altered epidermal lipid synthesis, contributing to increased dryness and sensitivity.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.